Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Stem Cell Therapy for Tissue Regeneration

Stem Cell Therapy for Tissue Regeneration

Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell types that...

Bone Marrow Sampling and Transplants

Bone Marrow Sampling and Transplants

Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Cost-effectiveness of stem cell therapy versus standard of care for acute and subacute ischemic stroke.

PloS one·2026

Same author

Serial brain FDG-PET and IMZ-SPECT following intracerebral MSC transplantation in patients with subacute ischemic stroke.

Stem cell research & therapy·2026

Same author

Efficacy and safety of stem cell therapy for acute and subacute ischemic stroke: a systematic review and meta-analysis.

Scientific reports·2025

Same author

A feasibility pilot study comparing tablets and smartphones for an app-based speed training program in older people: an open-label, randomized controlled PROBE trial.

Cognitive processing·2025

Same author

Intracerebral transplantation of MRI-trackable autologous bone marrow stromal cells for patients with subacute ischemic stroke.

Med (New York, N.Y.)·2024

Same author

Allogeneic Stem Cell Therapy for Acute Ischemic Stroke: The Phase 2/3 TREASURE Randomized Clinical Trial.

JAMA neurology·2024

Search research articles

Related Experiment Video

Updated: May 9, 2026

In Vivo Osteo-organoid Approach for Harvesting Therapeutic Hematopoietic Stem/Progenitor Cells

In Vivo Osteo-organoid Approach for Harvesting Therapeutic Hematopoietic Stem/Progenitor Cells

Published on: February 16, 2024

Translational challenge for bone marrow stroma cell therapy after stroke.

Satoshi Kuroda¹, Kiyohiro Houkin

¹Department of Neurosurgery, University of Toyama, Sugitani, Toyama, Japan. skuroda@med.u-toyama.ac.jp

Frontiers of Neurology and Neuroscience

|July 18, 2013

Summary

Bone marrow stromal cells (BMSC) show promise for treating central nervous system (CNS) damage, aiding functional recovery. Further research is needed to establish BMSC transplantation as a safe and effective clinical therapy for conditions like ischemic stroke.

More Related Videos

Protocol for MicroRNA Transfer into Adult Bone Marrow-derived Hematopoietic Stem Cells to Enable Cell Engineering Combined with Magnetic Targeting

Protocol for MicroRNA Transfer into Adult Bone Marrow-derived Hematopoietic Stem Cells to Enable Cell Engineering Combined with Magnetic Targeting

Published on: June 18, 2018

Related Experiment Videos

Last Updated: May 9, 2026

In Vivo Osteo-organoid Approach for Harvesting Therapeutic Hematopoietic Stem/Progenitor Cells

In Vivo Osteo-organoid Approach for Harvesting Therapeutic Hematopoietic Stem/Progenitor Cells

Published on: February 16, 2024

Protocol for MicroRNA Transfer into Adult Bone Marrow-derived Hematopoietic Stem Cells to Enable Cell Engineering Combined with Magnetic Targeting

Protocol for MicroRNA Transfer into Adult Bone Marrow-derived Hematopoietic Stem Cells to Enable Cell Engineering Combined with Magnetic Targeting

Published on: June 18, 2018

Area of Science:

Neuroscience
Regenerative Medicine
Cell Therapy

Background:

Bone marrow stromal cells (BMSC) demonstrate significant potential in promoting functional recovery following central nervous system (CNS) damage in animal models.
Conditions such as cerebral infarct and ischemic stroke show promise for BMSC-based therapies.

Purpose of the Study:

To review the current challenges and scientific contributions in establishing BMSC transplantation as a clinical therapy for CNS disorders.
To highlight the neuroprotective and regenerative capabilities of BMSC.

Main Methods:

Review of existing literature on BMSC transplantation for CNS disorders.
Discussion of BMSC properties, including neurotrophic factor production and neurite extension promotion.
In vitro expansion of BMSC using serum-free media and pharmacological modulation for proliferation.
In vivo tracking of transplanted BMSC using optical imaging and MRI.

Main Results:

BMSC possess the ability to protect neurons and promote neural circuit rebuilding in the injured CNS.
Transplanted BMSC can be successfully expanded in vitro and tracked noninvasively in vivo for extended periods.
Pharmacological interventions can enhance BMSC proliferation in vitro.

Conclusions:

BMSC transplantation holds significant therapeutic potential for CNS repair, particularly in ischemic stroke.
Further development of clinical imaging techniques is crucial for tracking transplanted cells and evaluating therapeutic efficacy.
Establishing standardized protocols and robust tracking methods are essential for the clinical translation of BMSC therapy.